Dr. Crilley on the Addition of Rituximab to Lymphoma Treatment

(1:10)

Rituximab and its biosimilars: consistencies and advantages

(48)

Dr. Andrew Zelenetz on the Impact of Rituximab in Lymphoma

(1:13)

Potential role of rituximab in mCRPC

(1:44)

FDA D.I.S.C.O. Burst Edition: FDA approvals of Rituxan (rituximab) plus chemotherapy for pediatri...

(7:1econd)

1st FLOR: nivolumab and rituximab in follicular lymphoma

(2:19)

Rituximab vs. standard chemotherapy: which treatment benefits B-cell ALL patients more?

(1:26)

IVAC +/- rituximab in R/R B-NHLs: a real-world data review

(6:38)

Using Rituximab in Non-Hodgkin Lymphoma

(6:47)

Monoclonal Antibodies – Rituximab \u0026 Obinutuzumab | Rebecca Beck, Lymphoma Australia

(40:12)

Follicular Lymphoma: Novel Approaches With Rituximab

(9:22)

Dr. Wierda on Role of Rituximab Biosimilar in Evolving CLL Treatment Paradigm

(1:39)

Rituximab in hematologic malignancies

(39:21)

Results Establishing Lenalidomide Plus Rituximab as Superior Treatment in Non-Hodgkin Lymphoma

(42)

Rituximab පිළිකා ඔසුවේ ප්‍රමිතිය සොයන්න කමිටුවක් - Hiru News

(1:34)

Naratuximab emtansine and rituximab in DLBCL

(7:37)

Dr. Kaplan Discusses Combinations With Rituximab for MCL

(1:15)

Rituximab in combination therapies for FL: Interim results

(5:39)

Hu5F9 plus rituximab to overcome resistance in refractory lymphoma

(12:38)

Dr. Schuster on Long-Term Outcomes of Lenalidomide and Rituximab in MCL

(2:10)